Patient Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SFIX
Stitch Fix
SFIX
|
+$3.76M |
| 2 |
Expedia Group
EXPE
|
+$3.48M |
| 3 |
GOOS
Canada Goose Holdings
GOOS
|
+$3.25M |
| 4 |
Coinbase
COIN
|
+$3.23M |
| 5 |
EXE
Expand Energy Corp
EXE
|
+$2.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$3.06M |
| 2 |
Vontier
VNT
|
+$2.94M |
| 3 |
AVID
Avid Technology Inc
AVID
|
+$2.25M |
| 4 |
DXC Technology
DXC
|
+$2.24M |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 31.21% |
| 2 | Financials | 16.02% |
| 3 | Energy | 12.88% |
| 4 | Technology | 11.18% |
| 5 | Industrials | 9.87% |
Similar funds
Patient Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Patient Capital Management held 45 positions worth $200M, down 11% from $226M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Patient Capital Management withdrew a net $13.2M in Q3 2022, closing 3 positions and reducing 17 holdings. Its most notable exit was Avid Technology Inc, an estimated $2.25M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 31% of assets, up from 27% a quarter earlier, followed by Financials and Energy.
Against the trend, Patient Capital Management opened a new position in Stitch Fix worth $2.62M.
- Patient Capital Management's largest Q3 2022 buy was Stitch Fix: 662,350 shares worth $2.62M.
- Patient Capital Management added most to Expedia Group in Q3 2022, an estimated $3.48M increase.
- Patient Capital Management's biggest Q3 2022 reduction was Alibaba, cutting an estimated $3.06M.
- Patient Capital Management fully exited Avid Technology Inc in Q3 2022, selling an estimated $2.25M.
- Patient Capital Management's ten largest holdings make up 44% of its $200M portfolio in Q3 2022.
- Patient Capital Management opened 4 new positions and closed 3 in Q3 2022.
- Patient Capital Management's portfolio value fell 11% quarter-over-quarter to $200M.
Based on Patient Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.